CE for Nurses

The Managing HL CE for Nurses section contains continuing educational activities focused on evidence-based scientific data and resources for nurses treating patients with Hodgkin lymphoma.

Stay up-to-date with recent advances in the management of HL and earn valuable continuing education contact hours.

Appropriate Treatment Approaches in Patients Through Every Stage of Hodgkin Lymphoma
Appropriate Treatment Approaches in Patients Through Every Stage of Hodgkin Lymphoma
CNE
Jonathon B. Cohen, MD, MS; Catherine Diefenbach, MD; Alison J. Moskowitz, MD; Sarah Rutherford, MD
Release Date: June 26, 2019
Expiration Date: June 26, 2020

This activity will address several practice-related issues regarding the management and treatment of patients with Hodgkin lymphoma (HL). Nurses who provide care to patients with HL may encounter clinical challenges regarding appropriate treatments and the adverse events associated with them. In this activity, you will hear from four experts focusing on topics including, but not limited to: emerging treatment regimens for newly diagnosed HL, recent clinical trials that are making an impact on the frontline management of advanced-stage cHL, current salvage treatment options for relapsed/refractory cHL, and CD30-directed therapy.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics, Inc.

Begin, Earn CreditView Only, No Credit
 
Evolving Care Strategies in Newly Diagnosed HL: Emerging Therapies and the Changing Role of the Oncology Nurse
Evolving Care Strategies in Newly Diagnosed HL: Emerging Therapies and the Changing Role of the Oncology Nurse
CNE
Amy L. Goodrich, RN, MSN, CRNP; Mollie E. Moran, MSN, CNP, AOCNP
Release Date: December 06, 2018
Expiration Date: December 06, 2019
New and emerging therapies are changing the treatment paradigms and care of patients with newly diagnosed advanced Hodgkin lymphoma. This symposium replay takes a closer look at these changes and their impact to nursing care. Our presenters provide an overview of the therapeutic treatment options and their known side-effect profiles which, if left unmanaged, could impact the overall progress and quality of life for patients. This activity includes presentations from our expert faculty on best strategies to employ in recognizing, treating, and long-term management of adverse events. We encourage you to listen in as faculty discuss the day-to-day educational needs of patients being treated for cHL.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Seattle Genetics, Inc.
View Only, CE ExpiredView Only, No Credit
 

MediCom Worldwide, Inc. would like to recognize and thank Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics for their educational support. To better serve the needs of our audience, ManagingHodgkinLymphoma.com is now ManagingLymphoma.com

©2019 MediCom Worldwide, Inc. All rights reserved